EcoDrugPlus

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSSAUG00010009020
Gene Symbol: YES1
1 Cross references
208 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSSAUG00010021049
Gene Symbol: ACHE
1 Cross references
231 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSSAUG00010021450
Gene Symbol: ACVR2B
1 Cross references
195 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSSAUG00010013730
Gene Symbol: ADORA1
3 Cross references
204 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSSAUG00010021157
Gene Symbol: ADORA2A
3 Cross references
189 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSSAUG00010007902
Gene Symbol: ADORA2A
3 Cross references
198 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSSAUG00010024950
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSSAUG00010026555
Gene Symbol: ADORA3
1 Cross references
137 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSSAUG00010000653
Gene Symbol: ADORA3
3 Cross references
139 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSSAUG00010008446
Gene Symbol: ADA
3 Cross references
216 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSSAUG00010026518
Gene Symbol: LOC115585599
3 Cross references
173 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSSAUG00010001773
Gene Symbol: ADRA1B
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).